|
CHICAGO, IL / ACCESSWIRE / June 4, 2023 / UCM Technologies has utilized a breakthrough combination of biomarkers CA62, CEA and CYFRA 211 to detect lung cancer at its earliest stages stages III with 93% sensitivity and 100% specificity.The CA62 cancer biomarker is a mesenchymal Nglycoprotein with a branched chain of polysaccharides, and is expressed on the surface of epithelialmesenchymal... Lire le communiqué |
